Implicit Racial Bias Impacts Psychiatric Diagnosis and Treatment, Study Finds
Researchers find that psychiatric diagnosis and treatment planning are susceptible to unconscious racial bias.
A new study in
Academic Psychiatry investigates the relationship between racial bias among psychiatrists and medical students in the US and the effects on diagnosis and treatment. The study, conducted by Amalia Londono Tobon from the Yale University School of Medicine and her colleagues, found rampant implicit racial bias among participants, which can have severe implications for their patients of color.
Tobon and colleagues measured the presence and strength of implicit associations and the relevance to how participants diagnose and treat patients and understand patient compliance. Implicit associations are unconscious, automatic, and non-deliberate judgments and thinking patterns that people might have about others. These could influence the quality of care they provide to people in those g
Most people who recover from COVID-19 have some protection against the coronavirus that causes this disease due to antibodies and other immune responses. But reinfections are possible. Experts are now learning more about how reinfections occur and what people can expect.
Family: Keyontae Johnson s medical emergency not related to. COVID diagnosis
Matt Stamey/AP
Florida s Keyontae Johnson is shown on the sidelines during the second half of an NCAA college basketball game Tuesday, Jan. 19. 2021, in Gainesville, Fla. Florida standout Keyontae Johnson has one of the best seats in the OâConnell Center. Heâs just a few feet from the court, close enough to hear calls, see screens coming and know where the ball needs to go next. (AP Photo/Matt Stamey)
By: WTXL Staff & Scripps National
Posted at 1:48 PM, Feb 03, 2021
and last updated 2021-02-03 16:49:15-05
TALLAHASSEE, Fla. â The family of Florida Gators forward Keyontae Johnson released a statement Tuesday that stated his collapse nearly two months ago during a game was not related to a positive COVID-19 test.
to Highlight Innovation and Opportunity in Kidney Health NEW YORK, Feb. 4, 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney diseases to drive improved patient outcomes and advance value-based care, announced today that it will co-host a Capital Markets Day for Kidney Health with the American Society of Nephrology (ASN) on Thursday, February 11 from 8:00 a.m. - 12:30 p.m. EST. The virtual event will bring together a broad group of delegates representing the kidney community, including leading clinicians, representatives of U.S. government health agencies, kidney care innovators and investors focused on life sciences and medical technology, for a series of presentations and panel discussions on the challenges and innovations arising from kidney health and the market opportunity in this area.
American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.